VWM
ASTH icon

Vermillion Wealth Management’s Astrana Health ASTH Stock Holding History

Vermillion Wealth Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14
Closed -$397 – 692
2025
Q3 		$397 Buy
+14
New +$379 ﹤0.01% 1490

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vermillion Wealth Management's ASTH Position: Q4 2025 in Review

Vermillion Wealth Management sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 14 shares — an estimated $397 sold.

Vermillion Wealth Management first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $397 in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Vermillion Wealth Management reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Vermillion Wealth Management sold 14 Astrana Health shares in Q4 2025, an estimated $397.
  • Vermillion Wealth Management first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
  • Vermillion Wealth Management's Astrana Health position peaked at $397 in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Vermillion Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.